Almaject
Specialized in the commercialization of generic injectable pharmaceuticals for the acute and alternate-site healthcare markets in the US
Almaject is a wholly owned subsidiary of Alvogen, focused on the development, acquisition, and commercialization of injectable generic pharmaceutical products across a broad range of therapeutic areas.
